201 related articles for article (PubMed ID: 23446076)
1. The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.
Tompkins DA; Smith MT; Bigelow GE; Moaddel R; Venkata SL; Strain EC
Clin J Pain; 2014 Jan; 30(1):36-45. PubMed ID: 23446076
[TBL] [Abstract][Full Text] [Related]
2. Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.
Leung A; Wallace MS; Ridgeway B; Yaksh T
Pain; 2001 Mar; 91(1-2):177-87. PubMed ID: 11240090
[TBL] [Abstract][Full Text] [Related]
3. Postdelivery of alfentanil and ketamine has no effect on intradermal capsaicin-induced pain and hyperalgesia.
Wallace MS; Braun J; Schulteis G
Clin J Pain; 2002; 18(6):373-9. PubMed ID: 12441831
[TBL] [Abstract][Full Text] [Related]
4. Opioid-Induced Hyperalgesia in the Nonsurgical Setting: A Systematic Review.
Yang DZ; Sin B; Beckhusen J; Xia D; Khaimova R; Iliev I
Am J Ther; 2019; 26(3):e397-e405. PubMed ID: 29726847
[TBL] [Abstract][Full Text] [Related]
5. Cold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine--a double-blind, cross-over comparison with alfentanil and placebo.
Jørum E; Warncke T; Stubhaug A
Pain; 2003 Feb; 101(3):229-235. PubMed ID: 12583865
[TBL] [Abstract][Full Text] [Related]
6. Evolution of Analgesic Tolerance and Opioid-Induced Hyperalgesia Over 6 Months: Double-Blind Randomized Trial Incorporating Experimental Pain Models.
Rowbotham MC; Wallace M
J Pain; 2020; 21(9-10):1031-1046. PubMed ID: 32006699
[TBL] [Abstract][Full Text] [Related]
7. Opioid-induced hyperalgesia from alfentanil.
Virani F; Miller M; Gilmour J
BMJ Support Palliat Care; 2020 Sep; 10(3):310-311. PubMed ID: 31467069
[TBL] [Abstract][Full Text] [Related]
8. Concentration-effect relationships for intravenous alfentanil and ketamine infusions in human volunteers: effects on acute thresholds and capsaicin-evoked hyperpathia.
Wallace MS; Ridgeway B; Leung A; Schulteis G; Yaksh TL
J Clin Pharmacol; 2002 Jan; 42(1):70-80. PubMed ID: 11808827
[TBL] [Abstract][Full Text] [Related]
9. Gradual withdrawal of remifentanil infusion may prevent opioid-induced hyperalgesia.
Comelon M; Raeder J; Stubhaug A; Nielsen CS; Draegni T; Lenz H
Br J Anaesth; 2016 Apr; 116(4):524-30. PubMed ID: 26934941
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects.
Park KM; Max MB; Robinovitz E; Gracely RH; Bennett GJ
Pain; 1995 Nov; 63(2):163-172. PubMed ID: 8628581
[TBL] [Abstract][Full Text] [Related]
11. Minocycline does not affect experimental pain or addiction-related outcomes in opioid maintained patients.
Arout CA; Waters AJ; MacLean RR; Compton P; Sofuoglu M
Psychopharmacology (Berl); 2019 Oct; 236(10):2857-2866. PubMed ID: 30564869
[TBL] [Abstract][Full Text] [Related]
12. Evidence of opioid-induced hyperalgesia in clinical populations after chronic opioid exposure: a systematic review and meta-analysis.
Higgins C; Smith BH; Matthews K
Br J Anaesth; 2019 Jun; 122(6):e114-e126. PubMed ID: 30915985
[TBL] [Abstract][Full Text] [Related]
13. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study.
Chu LF; Clark DJ; Angst MS
J Pain; 2006 Jan; 7(1):43-8. PubMed ID: 16414554
[TBL] [Abstract][Full Text] [Related]
14. Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans.
Lenz H; Raeder J; Draegni T; Heyerdahl F; Schmelz M; Stubhaug A
Pain; 2011 Jun; 152(6):1289-1297. PubMed ID: 21396775
[TBL] [Abstract][Full Text] [Related]
15. Clinical interpretation of opioid tolerance versus opioid-induced hyperalgesia.
Chen L; Sein M; Vo T; Amhmed S; Zhang Y; Hilaire KS; Houghton M; Mao J
J Opioid Manag; 2014; 10(6):383-93. PubMed ID: 25531956
[TBL] [Abstract][Full Text] [Related]
16. Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects.
Sethna NF; Liu M; Gracely R; Bennett GJ; Max MB
Anesth Analg; 1998 Jun; 86(6):1250-6. PubMed ID: 9620514
[TBL] [Abstract][Full Text] [Related]
17. Interaction of physostigmine and alfentanil in a human pain model.
Wehrfritz AP; Ihmsen H; Schmidt S; Müller C; Filitz J; Schüttler J; Koppert W
Br J Anaesth; 2010 Mar; 104(3):359-68. PubMed ID: 20047897
[TBL] [Abstract][Full Text] [Related]
18. [The clinical relevance of opioid-induced hyperalgesia remains unresolved].
Sørensen J; Sjøgren P
Ugeskr Laeger; 2011 Mar; 173(13):965-8. PubMed ID: 21453637
[TBL] [Abstract][Full Text] [Related]
19. Relative sensitivity to alfentanil and reliability of current perception threshold vs von Frey tactile stimulation and thermal sensory testing.
Park R; Wallace MS; Schulteis G
J Peripher Nerv Syst; 2001 Dec; 6(4):232-40. PubMed ID: 11800047
[TBL] [Abstract][Full Text] [Related]
20. Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats.
Wala EP; Sloan PA; Holtman JR
J Opioid Manag; 2011; 7(5):377-89. PubMed ID: 22165037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
